Product track
AISOF-3360
AI in Healthcare
Clinical and intended use safety for health AI.
Version 1.0. Published .

AISOF-3360
Healthcare
Why AISOF-3360 matters
Intended-use safety for a named healthcare AI product
AISOF-3360 is the AISOF® product framework for a single named healthcare product or service using AI. It is built for clinical and care-adjacent use.
Overview
Health AI touches diagnosis support, care pathways, triage, monitoring, and operational tools that still affect patients and clinicians. A corporate AI policy does not prove this product is fit for its intended use.
Regulators own device and clinical gates. AISOF-3360 offers a product-level integrity outcome under scheme rules that sits beside regulation without replacing it.
Outcomes are Certified or not Certified, determined only by Approved AISOF Assessors.
What sets this framework apart
Intended-use seriousness
Written for products that affect care and clinical-adjacent decisions.
Product scope
Certifies a named product or service. Does not certify the entire health system or every SKU.
Binary Certified outcome
Clear Certified or not Certified under scheme rules.
Assessor determination
Approved AISOF Assessors determine outcomes under the scheme.
Respects the legal gate
Does not replace medical device regulation or clinical licensing.
Family coherence
Same issuer discipline as other AISOF product frameworks: comparable claims and defined scope.
Who seeks AISOF-3360
- Digital health and medtech teams shipping AI into clinical or care-adjacent products
- Makers whose buyers ask for independent product assurance beyond a privacy policy
- Leaders who need a product mark that respects device and clinical law
- Companies that will not let one pilot tool stand for the whole portfolio
Organisation-wide AI governance is AISOF-3300. AISOF-3360 stays on the named healthcare product or service.
Public focus themes
The public themes of concern for AISOF-3360.
- Clinical and intended-use safety
- Human oversight and safe failure
- Health data governance
- Product security
- AI supply chain
- Post-market monitoring
- Incident and field safety response
Scheme materials. This page describes the purpose, scope and public themes of the framework. The detailed requirements, the assessment method used by Approved AISOF Assessors and the scoring approach are confidential scheme materials, issued under scheme terms with the assessment pack.
Scope: Does not replace medical device regulation or clinical licensing.


